Identification of a cross-talk between EGFR and Wnt/beta-catenin signaling pathways in HepG2 liver cancer cells

G Singh, MM Hossain, AQ Bhat, MO Ayaz, N Bano… - Cellular …, 2021 - Elsevier
EGFRis a transmembrane receptor tyrosine kinase involved in regulating cell proliferation,
differentiation and survival. EGFR is actively pursued as a therapeutic target because its …

EGF-induced ERK activation promotes CK2-mediated disassociation of α-catenin from β-catenin and transactivation of β-catenin

H Ji, J Wang, H Nika, D Hawke, S Keezer, Q Ge… - Molecular cell, 2009 - cell.com
Increased transcriptional activity of β-catenin resulting from Wnt/Wingless-dependent or-
independent signaling has been detected in many types of human cancer, but the …

Mechanism of β-catenin-mediated transcriptional regulation of epidermal growth factor receptor expression in glycogen synthase kinase 3 β-inactivated prostate …

KKN Guturi, T Mandal, A Chatterjee, M Sarkar… - Journal of Biological …, 2012 - ASBMB
Wnt/β-catenin and EGFR pathways are important in cancer development and often
aberrantly activated in human cancer. However, it is very important to understand the …

Knockdown of EGFR inhibits growth and invasion of gastric cancer cells

Y Zhen, L Guanghui, Z Xiefu - Cancer gene therapy, 2014 - nature.com
The epidermal growth factor receptor (EGFR) is an oncogenic trans-membranous receptor,
which is overexpressed in multiple human cancers. However, the role of EGFR in gastric …

Convergence between Wnt-β-catenin and EGFR signaling in cancer

T Hu, C Li - Molecular cancer, 2010 - Springer
Wnt and EGFR signaling play key roles in embryonic development and cell proliferation. It is
well documented that dysregulation of these two pathways often leads to tumorigenesis with …

EGFR signaling pathway as therapeutic target in human cancers

E Levantini, G Maroni, M Del Re, DG Tenen - Seminars in cancer biology, 2022 - Elsevier
Abstract Epidermal Growth Factor Receptor (EGFR) enacts major roles in the maintenance
of epithelial tissues. However, when EGFR signaling is altered, it becomes the grand …

Epidermal growth factor receptor variant III contributes to cancer stem cell phenotypes in invasive breast carcinoma

CA Del Vecchio, KC Jensen, RT Nitta, AH Shain… - Cancer research, 2012 - AACR
EGFRvIII is a tumor-specific variant of the epidermal growth factor receptor (EGFR). Although
EGFRvIII is most commonly found in glioblastoma, its expression in other tumor types …

[HTML][HTML] bFGF-mediated phosphorylation of δ-catenin increases its protein stability and the ability to induce the nuclear redistribution of β-catenin

G Chen, N An, Y Zhu, R Zhou, MG Noh… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Recently, we have shown that δ-catenin strengthened the epidermal growth factor receptor
(EGFR)/Erk1/2 signaling pathway through the association between EGFR and δ-catenin …

A novel EGFR isoform confers increased invasiveness to cancer cells

M Zhou, H Wang, K Zhou, X Luo, X Pan, B Shi, H Jiang… - Cancer research, 2013 - AACR
As a validated therapeutic target in several human cancers, the EGF receptor (EGFR)
provides a focus to gain deeper insights into cancer pathophysiology. In this study, we report …

Landscape of EGFR signaling network in human cancers: biology and therapeutic response in relation to receptor subcellular locations

W Han, HW Lo - Cancer letters, 2012 - Elsevier
The epidermal growth factor receptor (EGFR) pathway is one of the most dysregulated
molecular pathways in human cancers. Despite its well-established importance in tumor …